Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kura Oncology (KURA) EPS (Weighted Average and Diluted) (2023 - 2025)

Kura Oncology (KURA) has disclosed EPS (Weighted Average and Diluted) for 3 consecutive years, with -$0.92 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) fell 319.93% to -$0.92 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$0.92 through Dec 2025, up 54.49% year-over-year, with the annual reading at -$3.18 for FY2025, 57.43% down from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.92 at Kura Oncology, down from -$0.85 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was -$0.22 in Q4 2024, with the low at -$0.92 in Q4 2025.
  • Average EPS (Weighted Average and Diluted) over 3 years is -$0.61, with a median of -$0.59 recorded in 2024.
  • The sharpest move saw EPS (Weighted Average and Diluted) surged 60.0% in 2024, then tumbled 319.93% in 2025.
  • Over 3 years, EPS (Weighted Average and Diluted) stood at -$0.55 in 2023, then soared by 60.0% to -$0.22 in 2024, then crashed by 319.93% to -$0.92 in 2025.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods came in at -$0.92, -$0.85, and -$0.75 for Q4 2025, Q3 2025, and Q2 2025 respectively.